Table 2.
 Distribution of propensity scores*
| Propensity score in 20 groups* | Non-statin users | Statin users | ||
|---|---|---|---|---|
| No (%) | Deaths (%) | No (%) | Deaths (%) | |
| 1 | 576 (7.5) | 86 (15) | 1 (0.07) | 1 (100) |
| 2 | 576 (7.5) | 91 (16) | 2 (0.14) | 0 |
| 3 | 496 (6.5) | 81 (16) | 2 (0.14) | 0 |
| 4 | 470 (6.1) | 80 (17) | 2 (0.14) | 0 |
| 5 | 498 (6.5) | 69 (14) | 1 (0.07) | 0 |
| 6 | 451 (5.9) | 63 (14) | 5 (0.36) | 1 (20) |
| 7 | 425 (5.5) | 52 (12) | 6 (0.43) | 0 |
| 8 | 449 (5.9) | 66 (15) | 4 (0.29) | 0 |
| 9 | 374 (4.9) | 55 (15) | 8 (0.6) | 2 (25) |
| 10 | 404 (5.3) | 73 (18) | 13 (0.9) | 2 (15) |
| 11 | 390 (5.1) | 56 (14) | 17 (1.2) | 4 (24) |
| 12 | 368 (4.8) | 55 (15) | 22 (1.6) | 3 (14) |
| 13 | 333 (4.3) | 51 (15) | 24 (1.7) | 2 (8) |
| 14 | 325 (4.2) | 56 (17) | 39 (2.8) | 2 (5) |
| 15 | 311 (4.1) | 53 (17) | 36 (2.6) | 2 (6) |
| 16 | 325 (4.2) | 62 (19) | 83 (5.9) | 15 (18) |
| 17 | 365 (4.8) | 61 (17) | 145 (10.4) | 14 (10) |
| 18 | 250 (3.3) | 32 (13) | 239 (17.1) | 31 (13) |
| 19 | 170 (2.2) | 24 (14) | 316 (22.6) | 32 (10) |
| 20 | 119 (1.6) | 9 (8) | 433 (31.0) | 48 (11) |
*1=lowest likelihood of receiving statin; 20=highest likelihood of receiving statin; based on factors included in propensity score.